SOLAREDGE TECHN. DL-,0001/ US83417M1045 /
5/30/2024 10:00:55 AM | Chg. -0.260 | Volume | Bid10:00:55 AM | Ask10:00:55 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
44.590EUR | -0.58% | - Turnover: - |
44.590Bid Size: - | 44.895Ask Size: - | 2.58 bill.EUR | - | - |
GlobeNewswire
9:42 AM
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
9:01 AM
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
9:00 AM
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
9:00 AM
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
8:35 AM
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30 AM
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30 AM
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30 AM
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30 AM
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
GlobeNewswire
7:30 AM
Azerion announces expansion of its Executive Committee and new responsibilities